Comparisons of the risks of new-onset prostate cancer in type 2 diabetes mellitus between SGLT2I and DPP4I users: a population-based cohort study.
SGLT2I 與 DPP4I 使用者中,2 型糖尿病新發前列腺癌風險的比較:一項基於人群的隊列研究。
Diabetes Metab 2024-08-25
Comparing sodium-glucose cotransporter 2 inhibitors and dipeptidyl peptidase-4 inhibitors on new-onset depression: a propensity score-matched study in Hong Kong.
比較鈉葡萄糖共同轉運蛋白2抑制劑和二肽基胜肽酶-4抑制劑對香港新發抑鬱症的影響:一項傾向性配對研究。
Acta Diabetol 2023-05-22
Sodium-glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors on new-onset overall cancer in Type 2 diabetes mellitus: A population-based study.
二型糖尿病患者中鈉葡萄糖共同轉運蛋白2抑制劑與二肽基胜肽酶4抑制劑對新發生整體癌症的比較:一項基於人口的研究。
Cancer Med 2023-09-12
Comparison between sodium-glucose cotransporter 2 inhibitors and dipeptidyl peptidase 4 inhibitors on the risk of incident cancer in patients with diabetes mellitus: A real-world evidence study.
葡萄糖鈉共同運輸蛋白2抑制劑與二肽基胜肽酶4抑制劑在糖尿病患者中新發癌症風險的比較:一項真實世界證據研究。
Diabetes Metab Res Rev 2024-02-26
Incretin-based drugs decrease the incidence of prostate cancer in type 2 diabetics: A pooling-up analysis.
胰高血糖素類藥物降低第二型糖尿病患者攝護腺癌的發生率:一項集合分析。
Medicine (Baltimore) 2024-05-19
Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors for new-onset gastric cancer and gastric diseases in patients with type 2 diabetes mellitus: a population-based cohort study.
第二型糖尿病患者新發胃癌及胃疾病的鈉葡萄糖共同轉運蛋白2抑制劑的比較效果:一項基於人口的cohort研究。
Gastric Cancer 2024-06-10
Lower Risks of New-Onset Hepatocellular Carcinoma in Patients With Type 2 Diabetes Mellitus Treated With SGLT2 Inhibitors Versus DPP4 Inhibitors.
2型糖尿病患者使用SGLT2抑制劑治療相較於DPP4抑制劑,新發肝細胞癌風險降低。
J Natl Compr Canc Netw 2024-06-11
Type Disparity in Sodium-Glucose Cotransporter-2 Inhibitors in Incidences of Renal Cell Carcinoma: A Propensity-Score-Matched Cohort Study.
SGLT-2抑制劑在腎細胞癌發生率中的型別差異:一項傾向性配對的世代研究。
Cancers (Basel) 2024-06-19
Associations of SGLT-2i with Cardiorenal Outcomes Among Diabetics with Prostate Cancer on Hormone Therapy.
SGLT-2i 與接受荷爾蒙治療的前列腺癌糖尿病患者心腎結果的關聯性。
Res Sq 2024-08-07
The effect of SGLT2 inhibition on prostate cancer: Mendelian randomization and observational analysis using electronic healthcare and cohort data.
SGLT2 抑制對前列腺癌的影響:使用電子健康和隊列數據的孟德爾隨機化及觀察性分析。
Cell Rep Med 2024-08-21
Risk of dementia after initiation of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in adults aged 40-69 years with type 2 diabetes: population based cohort study.
在40-69歲的2型糖尿病成人中,啟用鈉-葡萄糖共轉運蛋白-2抑制劑與二肽基肽酶-4抑制劑後癡呆風險的比較:基於人群的隊列研究。
BMJ 2024-08-28